COR logo

COR

Cencora, Inc.NYSEHealthcare
$324.80+2.25%OpenMarket Cap: $63.18B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

38.88

PEG

2.37

P/B

33.06

P/S

0.19

EV/EBITDA

18.16

DCF Value

$602.82

FCF Yield

5.7%

Div Yield

0.7%

Margins & Returns

Gross Margin

3.3%

Operating Margin

1.2%

Net Margin

0.5%

ROE

101.4%

ROA

2.7%

ROIC

13.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 2026$85.93B$559.6M$2.87
Q4 2025$83.73B$-339.7M$-1.75
FY 2025$321.33B$1.55B$7.96
Q3 2025$80.66B$687.4M$3.52

Analyst Ratings

View All
BarclaysOverweight
2026-02-13
JP MorganOverweight
2026-02-10
Wells FargoOverweight
2026-02-10
Evercore ISI GroupOutperform
2026-02-05
Morgan StanleyOverweight
2026-01-29

Trading Activity

Insider Trades

View All
Krikorian Lazarusofficer: SVP & Chief Accounting Officer
SellThu Apr 02
Battaglia Silvanaofficer: Executive Vice President
SellFri Mar 13
Campbell Elizabeth Sofficer: Executive Vice President
SellFri Mar 13
Campbell Elizabeth Sofficer: Executive Vice President
SellFri Mar 13
Battaglia Silvanaofficer: Executive Vice President
SellFri Mar 13

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.72

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Peers